Delivery Order SPE2DB22D2206-SPE2DB24FKJ60

Award Date 9/16/24
Potential Completion Date 9/17/24
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,568,250 units of Methimazole 5 mg tablets. The contract has a ceiling value of $1,351.32 and a period of performance through May 15, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,007.36 and is for the supply of Methimazole 10 mg tablets in quantities of 100s. The contract is a Firm Fixed Price type and has an ultimate completion date of January 8, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,190.46, is for the delivery of 90 tablets of the drug Methimazole 5 mg. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a $1,351.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,248,039 units of the medication Methimazole 5 mg tablet, with a period of performance through May 15, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,567,111,751 Methimazole 10 mg tablets in 100-count bottles. The contract has a ceiling value of $3,943.13 and a completion date of February 3, 2025. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $1,385.67 and an ultimate completion date of December 5, 2022. It covers the procurement of 4,559,255,829 units of the medication Methimazole 5 mg tablets in 90-count packages. This award is not associated with a set-aside program. AmerisourceBergen, a for-profit...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for 180 tablets of the drug Methimazole 10 mg, with a ceiling value of $12,973.19 and a period of performance through April 3, 2024. AmerisourceBergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA that has a potential value of $999,999,999.00 and runs through December 31,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of 4,564,054,769 units of the pharmaceutical product methimazole 5 mg tablets. The total ceiling value of the contract is $2,674.19 and the period of performance runs through March 25, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,368.60 firm fixed price delivery order is for the supply of Methimazole 5 mg tablets. The contract has an ultimate completion date of June 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The award, valued at $1,943.30, is for the delivery of Methimazole 10 mg tablets over a period ending on August 16, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 and running through December 2025. This...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FKJ60
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Methimazole 10 mg tablets. The contract has a firm fixed price of $4,211.99 and a period of performance through September 17, 2024. The contract is not set aside for any specific business size or type. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which serves as a primary vehicle for providing a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide.

Generated 12/16/24, 2:37 PM